Concourse Financial Group Securities, Inc. Pro Phase Labs, Inc. Call Options Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PRPH
# of Institutions
34Shares Held
3.13MCall Options Held
26KPut Options Held
0-
Sykon Capital LLC Harrison, NY645KShares$193,4380.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA532KShares$159,5750.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA398KShares$119,3740.0% of portfolio
-
Geode Capital Management, LLC Boston, MA303KShares$90,8780.0% of portfolio
-
Accretive Wealth Partners, LLC Parsippany, NJ250KShares$75,0000.04% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $4.81M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...